Sulfamides as endothelin receptor antagonists for the treatment of cardiovascular diseases

Details for Australian Patent Application No. 2005303435 (hide)

Owner Actelion Pharmaceuticals Ltd.

Inventors Boss, Christoph; Bolli, Martin; Weller, Thomas; Fischli, Walter; Clozel, Martine

Agent A J Park

Pub. Number AU-A-2005303435

PCT Pub. Number WO2006/051502

Priority PCT/ EP2004/012774 11.11.04 EP

Filing date 11 November 2005

Wipo publication date 18 May 2006

International Classifications

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

28 June 2007 PCT application entered the National Phase

  PCT publication WO2006/051502 Priority application(s): WO2006/051502

19 November 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005303446-Antibacterial composition and methods thereof

2005303410-Fused tricyclic compounds as inhibitors of tumor necrosis factor-alpha